Immy

IMMY is a US-based organization dedicated to advancing mycology through the development, manufacture, and distribution of innovative diagnostic tests and reagents for fungal diseases. Their mission focuses on providing fast, reliable access to fungal disease diagnosis globally, addressing the rising burden of fungal infections affecting over a billion people each year.

Offering a comprehensive range of diagnostic solutions, IMMY specializes in rapid tests such as lateral flow assays, enzyme immunoassays, and polymerase chain reaction methods. These products aim to enhance patient care by ensuring accurate diagnosis and timely treatment, ultimately contributing to improved health outcomes in the face of rising fungal infection challenges.

Generated from the website